Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: idahoranch1 who wrote (7930)	10/21/2009 9:13:49 AM
From: li3511	Read Replies (2) \| Respond to of 63324

> There is more than Calvin and Martha. It isn't a story that might unfold 4 years > from now, it is already unfolding for some and some are benefiting. > > I'm curious to what you would do if you were diagnosed with stage lV PC tomorrow. I would find the best oncologist I could and take his advice. He would be informed about the MANY clinical trials in progress through conferences and literature. This brings us back to my original point: don't blame the analyst or anyone else for not recognizing the greatness of hPAM4, as you do, since Immunomedics has not published or presented any data about it yet. What am I to tell my hypothetical oncologist? That strangers on the Internet are making unverified claims about it? That anecdotes at an investor conference a year and a half ago were good? I might as well listen to Suzanne Somers for advice on how to treat it.